| Document |
Document Title |
|
WO/2023/155247A1 |
Provided are a single-molecular-weight amphiphilic fluorene-azobenzene oligomer, a self-assembled fiber, and a preparation method. The present invention diversifies and expands the studies of molecules having a backbone containing fluori...
|
|
WO/2023/137548A1 |
The present document describes a livestock dietary supplement composition which comprises a sialagogue comprising cinnamaldehyde, an anti-inflammatory comprising a salicylate, an expectorant comprising menthol, an antimicrobial comprisin...
|
|
WO/2023/140165A1 |
According to the present invention, a production method for a polyalcohol involves distillation refining a crude reaction liquid obtained by performing a reduction reaction on a starting material that is a polyaldehyde that has an alicyc...
|
|
WO/2023/134776A1 |
Methods for asymmetric cis-dihydroxylation ("AD") of quinones to produce cis-diols of quinones with high yield (i.e. a yield ≥ 30%) and high enantioselectivity (i.e. an enantiometric excess ≥ 30%) are disclosed. The method uses an ir...
|
|
WO/2023/132020A1 |
The present invention addresses the problem of providing: an oxygen-absorbing compound which has oxygen-absorbing properties and generates a reduced amount of odor; and an oxygen-absorbing adhesive composition and a coating agent composi...
|
|
WO/2023/104308A1 |
Suggested is the use of 4-cyclohexylbutan-2-one as a fragrance.
|
|
WO/2023/104159A1 |
The present invention relates to compounds as calcium channel blocker, a composition comprising thereof, use of said compounds and a method for treating diseases or disorders associated with calcium ion channel using said compounds. The ...
|
|
WO/2023/092076A1 |
The methods include treating cancer by the administration of an effective amount of acylfulvene to a subject in need thereof and an effective amount of radiation. The irradiation occurs before or concurrently with the administration of t...
|
|
WO/2023/056982A1 |
A herbicide compound, a preparation method therefor and an application thereof, the compound having a structure represented by formula (I), formula (II) or formula (III). The compound has a HPPD inhibitory effect, has a significant inhib...
|
|
WO/2023/015706A1 |
The present invention relates to a catalytic reaction, in particular, to a catalytic oxidation device and method. The catalytic oxidation device comprises a storage unit, a premixing unit, a microchannel reaction unit, a gas-liquid separ...
|
|
WO/2023/015709A1 |
Provided is a catalyst. Specifically, the present invention relates to a carbon-based metal-free functional quantum dot, a preparation method therefor and an application thereof. The preparation method comprises the following steps: S1: ...
|
|
WO/2023/006908A1 |
The present invention relates to the field of organic synthesis and, more specifically, it concerns a process for the preparation of an oxacylopentane or oxacylohexane derivative of formaul (II) comprising the cyclodehydration of a 1,4- ...
|
|
WO/2023/010119A1 |
A method of treating cancer includes a combination of a therapeutically effective amount of an illudin or an illudin analog thereof, derivative, or a pharmaceutically acceptable salt thereof; and a therapeutically effective amount of a P...
|
|
WO/2023/281040A1 |
The present invention relates to novel bi-functionalized trans-cyclooctenes of formula (I). It also relates to conjugates, compositions, medical uses of such compounds, and methods for producing such compounds as well as conjugates of su...
|
|
WO/2023/277347A1 |
The present invention relates to a tricyclodecane dimethanol composition in which the ratio of isomers is controlled, and a method for preparing same.
|
|
WO/2022/265240A1 |
The present invention relates to a tricyclodecane dimethanol composition in which the ratio of structural isomers is controlled, and a method for preparing same.
|
|
WO/2022/260947A1 |
Processes for converting a hydrocarbon reactant into an alcohol compound and/or a carbonyl compound are disclosed in which the hydrocarbon reactant and either a supported chromium (VI) catalyst or a supported chromium (II) catalyst are c...
|
|
WO/2022/255696A1 |
The present invention relates to: a tricyclodecane dimethanol composition which exhibits excellent solvent resistance and chemical resistance when forming a coating film, and can be suitably used for preparing a polyester resin having ex...
|
|
WO/2022/255695A1 |
The present invention relates to a tricyclodecane dimethanol composition and a preparation method therefor, wherein the composition wherein the composition has a reduced content of impurities and thus can be helpfully used in the prepara...
|
|
WO/2022/237904A1 |
A naphthalene ring-containing compound, a pharmaceutical composition containing same, and the use thereof. A naphthalene ring-containing compound as represented by formula III, a pharmaceutically acceptable salt thereof, a solvate thereo...
|
|
WO/2022/234590A1 |
The present invention discloses an industrial process for the manufacturing of Terpineol with controlled optical rotation range i.e., -12º to -14ºo. The Terpineol production process comprises of various steps including, separation of a...
|
|
WO/2022/227459A1 |
Disclosed are a polycarbonate and a synthesis method therefor, and a rigid monomer and a preparation method therefor. The polycarbonate comprises the structural unit as shown in formula (i) below; in addition, the polycarbonate can be sy...
|
|
WO/2022/224820A1 |
The present invention provides: a compound represented by formula I, formula I', formula II, or formula II'; and a composition that is for regulating circadian rhythm and that contains said compound or an Agrocybe erebia culture.
|
|
WO/2022/223117A1 |
The present invention relates to a method for preparing cis-cedrene diol, involving: providing alpha-cedrene in a solvent, which comprises or consists of water and at least one additional protic solvent; adding potassium permanganate and...
|
|
WO/2022/171652A2 |
The present invention relates to a method of hydrolysing bicyclic monoterpenes with an α/β-hydrolase-fold esterase being a carboxyl esterase comprising or consisting of an amino acid sequence with at least 80% identity to SEQ ID No. 1 ...
|
|
WO/2022/167266A1 |
The present invention provides an improved process for controlling an exothermic vapor phase hydrogenation of phenol that is catalyzed by a palladium comprising catalyst in an industrial scale hydrogenation reactor, wherein the reactor i...
|
|
WO/2022/164121A1 |
The present invention relates to a method for manufacturing a heterogeneous metal hydrogenation catalyst. More specifically, the present invention is characterized in that when the hydrogenation catalyst is reduced using a specific reduc...
|
|
WO/2022/154782A1 |
Systems and methods are provided for ozonolysis of polycyclic aromatic hydrocarbons (PAHs) in a liquid CO2 reaction environment. It has been unexpectedly discovered that oxygen- containing functional groups can be added to PAH substrates...
|
|
WO/2022/144482A1 |
The present invention relates to the synthesis and use of 12-DEOXYPHORBOL derivatives (or phorbol esters) to promote the differentiation of neurons from neural precursors or neural stem cells in culture and in the adult brain. The invent...
|
|
WO/2022/144436A1 |
The present invention refers to a process for the asymmetric synthesis of isopiperitenol and successor compounds.
|
|
WO/2022/147072A1 |
The methods include treating atypical teratoid/rhabdoid tumor by administration of HydroxyUreaMethyl Acylfulvene. Some embodiments relate to treatment of atypical teratoid/rhabdoid tumor by administration of HydroxyUreaMethyl Acylfulvene...
|
|
WO/2022/138748A1 |
The present invention provides a labeling method that comprises a step for labeling a substrate, which has a carbon-hydrogen bond, with an oxygen isotope with use of a catalyst and an oxidant that is produced from a hypervalent iodine co...
|
|
WO/2022/140580A1 |
The present invention provides for xanthophyll derivatives and compositions comprising the xanthophyll derivatives as well methods of making and using the same. The compositions include pharmaceutical compositions as well as foodstuffs, ...
|
|
WO/2022/129167A1 |
The present invention relates to new bicyclic compounds as aroma chemicals. Specifically, it relates to the use of bicyclic aroma compounds as an aroma chemical and also for enhancing and/or modifying the aroma of a composition.
|
|
WO/2022/127551A1 |
Disclosed are a hydrogenation catalyst, a preparation method for same, and applications thereof. Also disclosed is a hydrogenation reaction method employing the hydrogenation catalyst. The hydrogenation catalyst of the present invention ...
|
|
WO/2022/119792A1 |
Disclosed is a process for preparing 2,2,4,4-tetramethylcyclobutane- 1,3-diol by reacting 2,2,4,4-tetramethylcyclobutanedione with isobutanol in the presence of a tandem transfer hydrogenation and Tischenko reaction catalyst.
|
|
WO/2022/119793A1 |
Disclosed is a process for preparing 2,2,4,4-tetramethylcyclobutane-1,3-diol by reacting 2,2,4,4-tetramethylcyclobutanedione with a secondary alcohol in the presence of a transfer hydrogenation catalyst.
|
|
WO/2022/112118A1 |
The present invention relates to the field of organic synthesis. More specifically, it concerns a process for the selective reduction of a C3-C70 substrate containing one or more carbonyl or carboxylic functional groups into the correspo...
|
|
WO/2022/102544A1 |
Provided is a tobacco material in the form of a tobacco sheet or cut tobacco leaves, the tobacco material including a flavoring agent for tobaccos that comprises: (1) a cembratrienediol-containing tobacco extract produced by a method com...
|
|
WO/2022/102543A1 |
Provided is a production method for a tobacco extract containing cembratriendiol, the method comprising: a step 1 for preparing a discharged solid substance obtained from a tobacco raw material puffing process; a step 2 for subjecting th...
|
|
WO/2022/090464A1 |
The conversion of nootkatol to nootkatene in a terpene blend is mitigated or prevented by substantially or completely separating the nootkatols such as α-nootkatol from compounds present in the terpene blend that catalyze the chemical r...
|
|
WO/2022/082329A1 |
Disclosed herein are processes for preparing 3-fluoro-5-(((1S,2aR)-1,3,3,4,4- pentafluoro-2a-hydroxy-2,2a,3,4-tetrahydro-1H-cyclopenta[cd]
inden-7-yl)oxy)benzonitrile (hereinafter as compound (I) having the following structure).
|
|
WO/2022/086822A1 |
Disclosed herein are processes for preparing 3-fluoro-5-(((1S,2aR)-1,3,3,4,4-pentafluoro-2a-hydroxy-2,2a,
3,4-tetrahydro-1H-cyclopenta[cd]inden-7-yl)oxy)benzonitrile or a pharmaceutically acceptable salt thereof.
|
|
WO/2021/245579A1 |
The present invention relates to inhibitors of protein fucosylation. More specifically, the present invention relates to carbacyclic compounds of Formula (I) useful as inhibitors of protein fucosylation, or for treating a cancer, an auto...
|
|
WO/2021/227136A1 |
An enhanced reaction system and method for preparing cyclohexanone by selective hydrogenation of benzene. The system comprises a hydrogenation reactor (10); the hydrogenation reactor (10) is provided with a discharge port (11), and the d...
|
|
WO/2021/218197A1 |
An implementation method for promoting lignin depolymerization by pre-oxidation-catalytic hydrogenolysis, which comprises the steps of: pre-oxidizing lignin in a solvent system by using 2,3-dichloro-5,6-dicyanobenzoquinone (DDQ); then co...
|
|
WO/2021/207738A1 |
Methods for treating brain tumor cancer by administration hydroxyureamethyl-acylfulvene. Some embodiments relate to treatment of glioblastoma by administration of hydroxyureamethyl-acylfulvene. Method also includes characterizing the sub...
|
|
WO/2021/175864A1 |
The present invention relates to the field of organic synthesis and, more specifically, it concerns a process for preparing compound of formula (I) by a hydroboration-oxidation reaction of compound of formula (II).
|
|
WO/2021/175335A1 |
The present invention relates to an isopaucifloral F phosphate compound and a pharmaceutical use thereof. As verified by experiments, the isopaucifloral F phosphate compound and a pharmaceutically acceptable salt thereof is effective aga...
|
|
WO/2021/132876A1 |
The present invention relates to a method for producing 1,4-cyclohexanedimethanol (CHDM) and, more particularly, to a method for producing 1,4-cyclohexanedimethanol having a high proportion of trans isomers, without involving an isomeriz...
|
